Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-03
DOI
10.1186/s13045-020-00904-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the IGF1R/PI3K/AKT pathway sensitizes Ewing sarcoma to BET bromodomain inhibitors
- (2019) Sudan N Loganathan et al. MOLECULAR CANCER THERAPEUTICS
- Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
- (2019) Pietro Paolo Vitiello et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Caspase-3/PKCδ/Akt/VEGF-A Signaling Pathway Mediates Tumor Repopulation during Radiotherapy
- (2019) Qian Huang et al. CLINICAL CANCER RESEARCH
- Resistance to MAPK inhibitors in melanoma involves activation of the IGF-1R-MEK5-Erk5 pathway
- (2019) Lucía Benito-Jardón et al. CANCER RESEARCH
- Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells
- (2019) Xiang Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia
- (2019) Annika Scheffold et al. BLOOD
- Inhibition of didscoidin domain receptor 1 reduces epithelial–mesenchymal transition and induce cell‐cycle arrest and apoptosis in prostate cancer cell lines
- (2019) Reza Azizi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients
- (2019) Nadine Vewinger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating insulin‐like growth factor binding protein‐3 and risk of gastrointestinal malignant tumors
- (2019) Yasushi Adachi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
- (2019) Weiping Li et al. Journal of Hematology & Oncology
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
- (2019) Bhawana George et al. Journal of Hematology & Oncology
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor
- (2019) Alexandra Russo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer
- (2019) Yu-Hsuan Chen et al. Cancers
- Identification, Friend or Foe: Vimentin and α-Smooth Muscle Actin in Cancer-Associated Fibroblasts
- (2019) Sachiyo Nomura ANNALS OF SURGICAL ONCOLOGY
- Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection
- (2019) Veronica Vella et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
- (2019) Boheng Li et al. Journal of Hematology & Oncology
- Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study
- (2019) Margaret von Mehren et al. CLINICAL CANCER RESEARCH
- Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas
- (2018) Malik Bisserier et al. BLOOD
- Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI
- (2018) Marie Guerard et al. CANCER LETTERS
- Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis
- (2018) Hong Zhu et al. CANCER RESEARCH
- The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
- (2018) Javier Vaquero et al. CLINICAL CANCER RESEARCH
- Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer
- (2018) Adam J. Camblin et al. CLINICAL CANCER RESEARCH
- Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
- (2018) Crystal Lin et al. INTERNATIONAL JOURNAL OF CANCER
- A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC)
- (2018) Pedro Barata et al. INVESTIGATIONAL NEW DRUGS
- Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
- (2018) Reham Abdel-Wahab et al. Journal of Hematology & Oncology
- Anti-insulin-like growth factor therapy in breast cancer
- (2018) Douglas Yee JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity
- (2018) Ho Jin Lee et al. Molecular Cancer
- β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer
- (2018) Hani Lee et al. ONCOGENE
- Targeting IGF1R pathway in cancer with microRNAs: How close are we?
- (2018) Arathy S. Kumar et al. RNA Biology
- Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
- (2018) Sang Cheul Oh et al. Nature Communications
- Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
- (2018) Jei Ha Lee et al. Scientific Reports
- Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition
- (2018) Lingling Pian et al. Molecular Therapy-Nucleic Acids
- Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes
- (2018) Sreemathi Logan et al. Molecular Metabolism
- Restraining Akt1 Phosphorylation Attenuates the Repair of Radiation-Induced DNA Double-Strand Breaks and Reduces the Survival of Irradiated Cancer Cells
- (2018) Klaudia Szymonowicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer
- (2018) Jonatan Zorea et al. Cell Death & Disease
- SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
- (2018) Thomas Strub et al. Nature Communications
- Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells
- (2018) Yuzhe Yang et al. Hormones & Cancer
- A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
- (2018) Lillian M. Guenther et al. CLINICAL CANCER RESEARCH
- Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage
- (2017) Ahmed Waraky et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells
- (2017) Amy Lyons et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IGF-binding proteins
- (2017) L A Bach JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
- (2017) Hee-Joo Choi et al. JNCI-Journal of the National Cancer Institute
- IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
- (2017) Heming Li et al. Molecular Cancer
- The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy
- (2017) Michael P. Sanderson et al. MOLECULAR CANCER THERAPEUTICS
- Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition
- (2017) Sang-Oh Yoon et al. MOLECULAR CELL
- Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors
- (2017) Vanessa F. Merino et al. Molecular Oncology
- Polypharmacology-based ceritinib repurposing using integrated functional proteomics
- (2017) Brent M Kuenzi et al. Nature Chemical Biology
- Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma
- (2017) P. Moreno-Acosta et al. Radiation Oncology
- Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study
- (2017) Yasushi Adachi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response
- (2017) Robert Aiken et al. Oncotarget
- Targeting Cancer Cells with BET Bromodomain Inhibitors
- (2017) Yali Xu et al. Cold Spring Harbor Perspectives in Medicine
- Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
- (2017) Hee-Joo Choi et al. JNCI-Journal of the National Cancer Institute
- Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer
- (2017) Tali Cohen-Sinai et al. Frontiers in Endocrinology
- Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
- (2016) Lucy Ireland et al. CANCER RESEARCH
- Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway
- (2016) Annemiek M. van Maldegem et al. EUROPEAN JOURNAL OF CANCER
- Prediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition
- (2016) Aurora Perez-Cornago et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of Ligand and Shear Stress-induced Insulin-like Growth Factor 1 (IGF1) Signaling by the Integrin Pathway
- (2016) Candice G. T. Tahimic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma
- (2016) Salah-Eddine Lamhamedi-Cherradi et al. JNCI-Journal of the National Cancer Institute
- Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers
- (2016) Gloria Y. F. Ho et al. JNCI-Journal of the National Cancer Institute
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells
- (2016) K Tominaga et al. ONCOGENE
- A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
- (2016) Alberto A. Chiappori et al. ONCOLOGIST
- Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation
- (2016) Todd A. Triplett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer
- (2016) Chao Yao et al. STEM CELLS
- The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma
- (2016) Christine M. Heske et al. Translational Oncology
- Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein
- (2016) Dudi Warsito et al. Oncotarget
- Type I insulin-like growth factor receptor signaling in hematological malignancies
- (2016) Deeksha Vishwamitra et al. Oncotarget
- IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin
- (2016) Ciara H. O’Flanagan et al. Oncotarget
- IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma
- (2016) Salah-Eddine Lamhamedi-Cherradi et al. JNCI-Journal of the National Cancer Institute
- Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers
- (2016) Gloria Y. F. Ho et al. JNCI-Journal of the National Cancer Institute
- IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma
- (2016) Matthew N. Svalina et al. Scientific Reports
- A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial†
- (2015) C. S. Fuchs et al. ANNALS OF ONCOLOGY
- IGF-IR: a new prognostic biomarker for human glioblastoma
- (2015) C Maris et al. BRITISH JOURNAL OF CANCER
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis
- (2015) Yeong Sook Yoon et al. Cancer Epidemiology
- p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem–like Features via miR-885-5p Control
- (2015) Claudia Meier et al. CANCER RESEARCH
- Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases
- (2015) Hideko Isozaki et al. CANCER RESEARCH
- IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer
- (2015) O. T. Dale et al. CARCINOGENESIS
- mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
- (2015) Yancun Yin et al. CELL RESEARCH
- Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity
- (2015) X. Wang et al. CLINICAL CANCER RESEARCH
- InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma
- (2015) Y. Ma et al. CLINICAL CANCER RESEARCH
- Highly specific role of the insulin receptor in breast cancer progression
- (2015) R. Rostoker et al. ENDOCRINE-RELATED CANCER
- Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
- (2015) Victoria Tovar et al. GUT
- IGF-IR determines the fates of BCR/ABL leukemia
- (2015) Jingjing Xie et al. Journal of Hematology & Oncology
- A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory,KRASWild-Type, Metastatic Colorectal Cancer
- (2015) Francesco Sclafani et al. JNCI-Journal of the National Cancer Institute
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- (2015) Martin Fassnacht et al. LANCET ONCOLOGY
- Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor
- (2015) A. Forest et al. MOLECULAR CANCER RESEARCH
- Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
- (2015) Xin Ye et al. NATURE
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
- (2015) Ji-Sun Lee et al. Nature Communications
- ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents
- (2015) Caterina Mancarella et al. Oncotarget
- FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells
- (2015) LaTonia Taliaferro-Smith et al. Oncotarget
- IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide
- (2015) Roger Ramcharan et al. Oncotarget
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory,KRASWild-Type, Metastatic Colorectal Cancer
- (2015) Francesco Sclafani et al. JNCI-Journal of the National Cancer Institute
- IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
- (2015) Xiaolin Wan et al. NEOPLASIA
- Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation
- (2015) Susan M. Farabaugh et al. Frontiers in Endocrinology
- Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients
- (2015) Sandra Heskamp et al. PLoS One
- A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal
- (2015) Filip Janku et al. Oncotarget
- IGF-1R inhibition potentiates cytotoxic effects of chemotherapeutic agents in early stages of chemoresistant ovarian cancer cells
- (2014) Ram K. Singh et al. CANCER LETTERS
- IGF-I Regulates Redox Status in Breast Cancer Cells by Activating the Amino Acid Transport Molecule xC−
- (2014) Yuzhe Yang et al. CANCER RESEARCH
- Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors
- (2014) P. Haluska et al. CLINICAL CANCER RESEARCH
- Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer
- (2014) E. Van Cutsem et al. CLINICAL CANCER RESEARCH
- Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition
- (2014) Kunal A. Lodhia et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours
- (2014) Haruo Iguchi et al. INVESTIGATIONAL NEW DRUGS
- A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer
- (2014) Johanna C. Bendell et al. INVESTIGATIONAL NEW DRUGS
- GSK3 Protein Positively Regulates Type I Insulin-like Growth Factor Receptor through Forkhead Transcription Factors FOXO1/3/4
- (2014) Xiaodong Huo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PTEN Deficiency Mediates a Reciprocal Response to IGFI and mTOR Inhibition
- (2014) Mukund Patel et al. MOLECULAR CANCER RESEARCH
- IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines
- (2014) F. Huang et al. MOLECULAR CANCER THERAPEUTICS
- The Tyrphostin NT157 Suppresses Insulin Receptor Substrates and Augments Therapeutic Response of Prostate Cancer
- (2014) N. Ibuki et al. MOLECULAR CANCER THERAPEUTICS
- Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer
- (2014) Christine M Lovly et al. NATURE MEDICINE
- Nuclear translocation of IGF-1R via p150Glued and an importin-β/RanBP2-dependent pathway in cancer cells
- (2014) S Packham et al. ONCOGENE
- Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes
- (2014) Giannis Mountzios et al. PLoS One
- Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
- (2014) Wan-Jiun Chen et al. Nature Communications
- Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies
- (2013) ANNALS OF INTERNAL MEDICINE
- IGF-1R and ErbB3/HER3 contribute to enhanced proliferation and carcinogenesis in trastuzumab-resistant ovarian cancer model
- (2013) Yanhan Jia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia
- (2013) N. Yaktapour et al. BLOOD
- The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin
- (2013) Quan Wang et al. BMC CANCER
- DNp73 Exerts Function in Metastasis Initiation by Disconnecting the Inhibitory Role of EPLIN on IGF1R-AKT/STAT3 Signaling
- (2013) Marc Steder et al. CANCER CELL
- Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment
- (2013) H. Reuveni et al. CANCER RESEARCH
- -Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma
- (2013) C. Xu et al. CANCER RESEARCH
- Putative Predictive Biomarkers of Survival in Patients with Metastatic Pancreatic Adenocarcinoma Treated with Gemcitabine and Ganitumab, an IGF1R Inhibitor
- (2013) I. McCaffery et al. CLINICAL CANCER RESEARCH
- IGF2 increases de novo steroidogenesis in prostate cancer cells
- (2013) Amy A Lubik et al. ENDOCRINE-RELATED CANCER
- An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
- (2013) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Ligand-independent activation of MET through IGF-1/IGF-1R signaling
- (2013) Andreas Varkaris et al. INTERNATIONAL JOURNAL OF CANCER
- Combating Resistance to Anti-IGFR Antibody by Targeting the Integrin β 3-Src Pathway
- (2013) Dong Hoon Shin et al. JNCI-Journal of the National Cancer Institute
- Dynamic and Nuclear Expression of PDGFR and IGF-1R in Alveolar Rhabdomyosarcoma
- (2013) M. I. Aslam et al. MOLECULAR CANCER RESEARCH
- Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)
- (2013) A. Pavlicek et al. MOLECULAR CANCER THERAPEUTICS
- Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts
- (2013) C. D. Fahrenholtz et al. MOLECULAR CANCER THERAPEUTICS
- IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy
- (2013) C. Ferte et al. MOLECULAR CANCER THERAPEUTICS
- IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination
- (2013) M M Chitnis et al. ONCOGENE
- Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling
- (2013) I G Kim et al. ONCOGENE
- Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
- (2012) D. J. Kuhn et al. BLOOD
- Insulin-like Growth Factor-I Concentration and Risk of Prostate Cancer: Results from the European Prospective Investigation into Cancer and Nutrition
- (2012) A. J. Price et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP
- (2012) Katrin Straßburger et al. DEVELOPMENTAL BIOLOGY
- Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF
- (2012) Dudi Warsito et al. EMBO REPORTS
- Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
- (2012) Irène Asmane et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
- (2012) William D. Tap et al. JOURNAL OF CLINICAL ONCOLOGY
- IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors
- (2012) V. Evdokimova et al. Science Signaling
- Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
- (2011) Rinat Yerushalmi et al. BREAST CANCER RESEARCH AND TREATMENT
- Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor
- (2011) Xianke Zeng et al. BREAST CANCER RESEARCH AND TREATMENT
- A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
- (2011) E. M. Fox et al. CANCER RESEARCH
- IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration
- (2011) Dawn V. Jaquish et al. CARCINOGENESIS
- Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and AutoregulatesIGF-IRGene Expression in Breast Cancer Cells
- (2011) Rive Sarfstein et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer
- (2011) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
- (2011) Heribert Juergens et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling
- (2011) Hind Medyouf et al. JOURNAL OF EXPERIMENTAL MEDICINE
- LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis
- (2011) Huili Li et al. Molecular Cancer
- Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma
- (2011) J. Abraham et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial-Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines
- (2011) H. Zhao et al. MOLECULAR CANCER THERAPEUTICS
- Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-like Growth Factor I Receptor Monoclonal Antibody
- (2011) D. H. Shin et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
- (2011) C Garofalo et al. ONCOGENE
- Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9
- (2010) Hua Deng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model
- (2010) F. Huang et al. CANCER RESEARCH
- Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas
- (2010) J. C. Potratz et al. CANCER RESEARCH
- Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells
- (2010) T. Aleksic et al. CANCER RESEARCH
- The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models
- (2010) S. A. Flanigan et al. CLINICAL CANCER RESEARCH
- Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma
- (2010) Gloria Peiró et al. MODERN PATHOLOGY
- Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
- (2010) E. Buck et al. MOLECULAR CANCER THERAPEUTICS
- Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
- (2010) D. B. Ulanet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor
- (2010) B. Sehat et al. Science Signaling
- IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
- (2009) P. Shi et al. BLOOD
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
- (2009) C. Desbois-Mouthon et al. CLINICAL CANCER RESEARCH
- BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide
- (2009) Marie-Claude Beauchamp et al. GYNECOLOGIC ONCOLOGY
- The Direct Binding of Insulin-like Growth Factor-1 (IGF-1) to Integrin αvβ3 Is Involved in IGF-1 Signaling
- (2009) Jun Saegusa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival
- (2009) D Sachdev et al. ONCOGENE
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
- (2008) Chad J. Creighton et al. JOURNAL OF CLINICAL ONCOLOGY
- Bcr-Abl induces autocrine IGF-1 signaling
- (2008) A Lakshmikuttyamma et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More